| Followers | 4045 |
| Posts | 152978 |
| Boards Moderated | 3 |
| Alias Born | 08/05/2009 |
Tuesday, September 26, 2023 2:21:21 PM
short avg 41.07
Bearish
Recent IMVT News
- Breakthrough Pipelines Ignite Investor Excitement: Retatrutide, VERVE-102, NEO100, and More Set to Transform Medicine • GlobeNewswire Inc. • 05/27/2026 12:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:03:32 PM
- Immunovant Shares Rally on Positive Trial Results Despite Earnings Miss (IMVT) • IH Market News • 05/20/2026 12:49:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/20/2026 11:28:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 11:14:07 AM
- Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 • GlobeNewswire Inc. • 05/20/2026 11:00:00 AM
- Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026 • GlobeNewswire Inc. • 05/11/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 10:40:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2026 08:46:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 08:05:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 08:03:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 08:22:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 08:20:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 08:17:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 08:13:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:33:01 PM
- Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED) • GlobeNewswire Inc. • 04/02/2026 09:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:07:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/10/2026 10:16:55 PM
- Immunovant shares climb 7% as fiscal Q3 loss comes in better than expected • IH Market News • 02/06/2026 03:50:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/06/2026 12:24:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 12:16:39 PM
- Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025 • GlobeNewswire Inc. • 02/06/2026 12:00:00 PM
- Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026 • GlobeNewswire Inc. • 01/23/2026 10:25:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2025 09:15:25 PM

